Share blood samples to help study blood cancers and treatments
Part of Blood & lymphatic, Cancer, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You want to share your information and samples for research
- You can understand the study and are willing to sign written consent
- If you have cancer: you may join whether your cancer is active or in long-term remission
- If you don’t have cancer: you must not have a past or current history of blood cancer or solid tumors
- If you are pregnant, you cannot enroll
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cells talk to each other in hairy cell leukemia, a rare blood cancer. It aims to find ways to improve patient care. Participants may be asked to give blood or tissue samples for research.
This study looks at tiny particles called extracellular vesicles in the blood of people with Hairy Cell Leukemia. Researchers want to understand if these particles can help improve how the disease is managed and followed.
This study creates lab models from blood samples of people with specific mature B-cell blood cancers (CLL, SMZL, HCL) to test new immune and combination treatments. This research may help find more personalized therapies for these diseases.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
This study collects leftover tissue samples from patients with or without lymphoma to help researchers better understand lymph system cancers. It may be an option if you are already having a biopsy or surgery.
Hear when a new Hairy Cell Leukemia (HCL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.